Here's the scoop on the treatment, diagnosis, and definition of the primary brain lymphoma that landed Raphael in the ...

At the recent American Society of Hematology annual meeting, early data from the Mithic-FL1 Trial demonstrated impressive ...

Scientists have discovered that our specialized immune cells, called T cells, are what they eat -- their switch from functional to 'exhausted' depends on the switch from metabolizing acetate to ...

SAN DIEGO — Mantle cell lymphoma patients who go into deep remission from a first therapy may not get any benefit from a follow-up transplant of their stem cells, according to a new study.

There are many different types of B-cell lymphomas. Two of the most common B-cell lymphomas are diffuse large B-cell lymphoma (DLBCL ... the CD20 cells of FL and the CD3 cells of cytotoxic T cells, ...

She's a journalist who was born and raised in Texas, although she spent time living in NYC and LA as well. When the news dropped in June that T&T would be opening a massive U.S. flagship store in ...

is not beneficial for patients with mantle cell lymphoma (MCL) in first complete remission (CR) with undetectable minimal residual disease (uMRD), according to a study to be presented at the annual ...

But now, scientists at UC San Francisco may have found a more precise way to dial it down. The technology uses engineered T cells that act as immune “referees” to soothe overreacting immune responses.

which hunt down and destroy infected cells. This discovery, and the fact that the same isn’t true of men, could help to explain why women are less likely to catch infections but have higher ...

Paulina Velasquez, MD, discusses the differences between T-cell receptor-based and chimeric antigen receptor T-cell therapies. Paulina Velasquez, MD, assistant faculty member, St. Jude Children’s ...

Multiphenotypic cervical carcinoma is a rare tumor that resembles HPV-related multiphenotypic sinonasal carcinoma ... consistent with squamous cell carcinoma. A subsequent gynecological examination ...